logo

For the Inventor, By the Inventor

Sandwich, United Kingdom

Anthony Wood

This inventor holds 24 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Pfizer Corporation, Agouron Pharmaceuticals, Inc.. Active years: 1999-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony Wood. Retrieved from https://idiyas.com/inventor/anthony-wood

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 83.3



Average Co-Inventor Count = 4.1

ph-index = 9

Forward Citations = 349(Granted Patents)


Location History:

  • Kent, GB (2003)
  • County of Kent, GB (2003 - 2004)
  • Margate, GB (2006 - 2007)
  • Sandwich, GB (1999 - 2013)

Company Filing History:

goldMedal21 out of 4,488 
 
Pfizer Corporation
 patents
silverMedal3 out of 174 
 
Agouron Pharmaceuticals, Inc.
 patents

Years Active: 1999-2013

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Carboxamide Derivatives
Muscarinic Receptor Antagonists
Tropane Derivatives
CCR5 Modulators
Pyrazole Derivatives
cGMP PDE5 Inhibitors
Erectile Dysfunction
Sexual Dysfunction
Phosphodiesterase Inhibition
Pyrazolopyrimidinones
Therapeutic Applications
24 patents (USPTO):Explore Patents
1. 8486992 - Carboxamide derivatives as muscarinic receptor antagonists (2013-07-16),
2. 8268881 - Carboxamide derivatives as muscarinic receptor antagonists (2012-09-18),
3. 7772223 - Carboxamide derivatives as muscarinic receptor antagonists (2010-08-10),
4. 7579471 - Tropane derivatives useful in therapy (2009-08-25),
5. 7576097 - Tropane derivatives useful in therapy (2009-08-18),
6. 7368460 - Tropane derivatives useful in therapy (2008-05-06),
7. 7217721 - Tropane derivatives useful in therapy (2007-05-15),
8. 7217714 - CCR5 modulators (2007-05-15),
9. 7141585 - Pyrazole derivatives (2006-11-28),
10. 7041667 - CCR5 modulators (2006-05-09),
11. 6916927 - Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5′-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction (2005-07-12),
12. 6855724 - Tropane derivatives useful in therapy (2005-02-15),
13. 6750230 - Pyrazole derivatives (2004-06-15),
14. 6723719 - Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′—monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction (2004-04-20),
15. 6670366 - Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction (2003-12-30),

Title: Anthony Wood: Innovator in Pharmaceutical Chemistry

Introduction: Anthony Wood, located in Sandwich, GB, is a prominent inventor known for his significant contributions to the field of pharmaceutical chemistry. With a remarkable total of 24 patents to his name, Wood has established himself as a key figure in developing innovative compounds that advance medical science.

Latest Patents: Among his latest innovations are the patents for Carboxamide derivatives as muscarinic receptor antagonists. These inventions relate to compounds characterized by specific formulas, detailing the processes and intermediates for their preparation. Additionally, these compounds are recognized for their utility as muscarinic antagonists and in pharmaceutical compositions that incorporate them.

Career Highlights: Wood has had an illustrious career, working with renowned companies such as Pfizer Corporation and Agouron Pharmaceuticals, Inc. His experience in these organizations has undoubtedly shaped his expertise in drug development and innovation.

Collaborations: Throughout his career, Wood has collaborated with notable professionals in the industry, including Manoussos Perros and Mark Edward Bunnage. These collaborations have likely contributed to the evolution of his pioneering work in the pharmaceutical sector.

Conclusion: Anthony Wood's extensive patent portfolio and successful collaborations mark him as a leading innovator in pharmaceutical chemistry. His commitment to advancing medical therapies through innovative compounds plays a vital role in the development of new pharmacological treatments, impacting health and wellness positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…